Fly Agaric and Sleep: What First-Line Insomnia Care Actually Looks Like

Fly agaric is not part of any recognised insomnia treatment. Clinical guidelines recommend cognitive behavioural therapy for insomnia (CBT-I) as the first treatment for chronic insomnia. Medication comes second, under medical supervision. Most supplements are not recommended at all, and the US FDA does not consider Amanita muscaria safe for use in food.

What do clinical guidelines recommend first for insomnia?

Two major guidelines agree on the starting point. In 2016 the American College of Physicians recommended that all adults with chronic insomnia disorder receive CBT-I as the initial treatment (Qaseem et al., Annals of Internal Medicine, 2016).

The American Academy of Sleep Medicine reached a similar conclusion in 2021. Its guideline on behavioural and psychological treatments strongly recommends multicomponent CBT-I for adults with chronic insomnia (Edinger et al., Journal of Clinical Sleep Medicine, 2021).

Chronic insomnia usually means trouble falling or staying asleep at least three nights a week for three months or more, with daytime consequences. Shorter bouts are common and often pass on their own, especially after a stressful event.

What CBT-I actually involves

CBT-I is a structured programme, usually delivered over several weeks by a trained clinician, in a group, or through a validated digital programme. It is not a single tip or a relaxation app.

The AASM guideline lists the components with evidence behind them. They include stimulus control, sleep restriction therapy and relaxation therapy, each supported as a single-component option as well (Edinger et al., 2021).

• Stimulus control rebuilds the link between bed and sleep, rather than bed and wakeful worry.
• Sleep restriction temporarily limits time in bed to consolidate sleep, then gradually extends it. It should be supervised, because it causes short-term sleepiness.
• Cognitive therapy targets the anxious beliefs about sleep that keep people awake.
• Relaxation training lowers physical tension before bed.

One finding surprises many people. The same guideline suggests that sleep hygiene should not be used as a stand-alone treatment for chronic insomnia. Advice about caffeine, screens and bedroom temperature is sensible, but on its own it is usually not enough.

Access is the most common barrier. Trained CBT-I therapists are scarce in many areas, so a GP may suggest a group course or a validated digital programme instead. Asking for a referral is a reasonable first step for anyone whose poor sleep has lasted for months.

Where medication sits

Medication is a second step, not the first. The ACP recommends a shared decision between patient and clinician about short-term medication when CBT-I alone has not worked (Qaseem et al., 2016).

That discussion covers benefits, harms and costs. Prescription sleep medicines can cause next-day drowsiness, falls and dependence, so they are chosen carefully and reviewed regularly.

Clinicians also look for other causes before treating insomnia itself. Sleep apnoea, restless legs, depression, chronic pain, thyroid problems and some medications can all disrupt sleep. A supplement cannot rule any of these out.

Where do supplements and fly agaric sit?

Mostly outside the guidelines. The AASM's 2017 guideline on sleep medications suggested that clinicians not use valerian, melatonin, L-tryptophan or diphenhydramine to treat chronic insomnia in adults (Sateia et al., Journal of Clinical Sleep Medicine, 2017). These were weak recommendations based on limited evidence, but they show how high the bar is.

Fly agaric does not even reach the starting line. It has no clinical trials for sleep, no standardised preparation and a documented record of poisoning. In September 2024 the FDA concluded that Amanita muscaria and its active compounds are not generally recognised as safe for use in food (FDA Scientific Memorandum, 2024).

There is also an opportunity cost. Time spent experimenting with an unproven substance is time not spent on a treatment that works, and it may delay diagnosis of a treatable condition. Our article asking whether fly agaric can help sleep safely looks at the pharmacology behind that answer, and sleep and fly agaric: facts, risks and safer sleep tips covers the risk side.

Important: This article is educational content, not medical advice. Amanita muscaria is toxic, and Amanita Store does not sell it for ingestion. If insomnia lasts more than a few weeks or affects your daytime life, see a doctor, who can assess causes and refer you for CBT-I. If you suspect mushroom poisoning, call emergency services or your local poison control centre immediately.

Frequently Asked Questions

What is the first-line treatment for chronic insomnia?

Cognitive behavioural therapy for insomnia (CBT-I). The American College of Physicians and the American Academy of Sleep Medicine both recommend it as the initial treatment for adults.

Is sleep hygiene enough to treat insomnia?

Usually not on its own. The AASM suggests sleep hygiene should not be used as a stand-alone treatment for chronic insomnia, though it can be part of a wider CBT-I programme.

Do sleep guidelines recommend any herbal supplements?

No. The AASM's 2017 guideline suggested that clinicians not use valerian, melatonin or L-tryptophan for chronic insomnia, based on weak evidence.

Does fly agaric improve sleep?

There is no clinical evidence that it does. It has never been tested in a sleep trial, and the FDA does not consider it safe for use in food.

When should I see a doctor about sleep?

If poor sleep lasts more than a few weeks, affects your mood or daytime functioning, or comes with loud snoring or breathing pauses, see a doctor.